Customized guidance simplifies managing obstacles, monitoring outcomes, and shifting directions when necessary
Sanyal et al., Nat Med, 2024) has examined endpoints relevant to obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD) under controlled clinical research protocols
If you are experiencing side effects with semaglutide, trying liraglutide (a daily injection with a shorter half-life) may be easier to tolerate than once-weekly options for some patients
The inclusion in another largely unexplored dimension, as the potential role it may have on the gut-microbiota-brain axis is also interesting
Patient commitment counts
GLP-1 : Does It Really Work